Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)

M. Esposito; P. Gisondi; C. Assorgi; F. Bellinato; P. Brianti; M. Burlando; G. Brunasso; S. Caccavale; Giacomo Caldarola; E. Campione; Pinton P. Calzavara; A. Campanati; C. G. Carrera; A. Carugno; E. Cozzani; A. Costanzo; F. Cusano; P. Dapavo; A. Dattola; Clara De Simone; Caprio R. Di; F. Diotallevi; M. C. Fargnoli; F. Gaiani; A. Giunta; P. Malagoli; A. V. Marzano; M. Megna; S. R. Mercuri; E. Mortato; A. Narcisi; D. Orsini; L. Potestio; P. Quaglino; A. G. Richetta; F. Romano; P. Sena; E. Vagnozzi; M. Venturini; F. Loconsole; A. Balato

doi:10.1007/s40261-025-01440-z

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)

M. Esposito^*
, P. Gisondi
, C. Assorgi
, F. Bellinato
, P. Brianti
, M. Burlando
, G. Brunasso
, S. Caccavale
, Giacomo Caldarola
, E. Campione
, Pinton P. Calzavara
, A. Campanati
, C. G. Carrera
, A. Carugno
, E. Cozzani
, A. Costanzo
, F. Cusano
, P. Dapavo
, A. Dattola
, Clara De Simone

Caprio R. Di, F. Diotallevi, M. C. Fargnoli, F. Gaiani, A. Giunta, P. Malagoli, A. V. Marzano, M. Megna, S. R. Mercuri, E. Mortato, A. Narcisi, D. Orsini, L. Potestio, P. Quaglino, A. G. Richetta, F. Romano, P. Sena, E. Vagnozzi, M. Venturini, F. Loconsole, A. Balato

^*Corresponding author

University of L'Aquila
University of Verona
IRCCS Istituto Dermatologico Santa Maria e San Gallicano – Roma
University of Naples Federico II
Vita-Salute San Raffaele University
San Martino Hospital Genoa
E.O. Ospedali Galliera
University of Campania Luigi Vanvitelli
University of Rome Tor Vergata
University of Brescia
Marche Polytechnic University
ASST Papa Giovanni XXIII
University of Milan - Bicocca
IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
Azienda Ospedaliera G. Rummo
University of Turin
University of Rome La Sapienza
Fatebenefratelli Hospital
University of Bari
Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	309-315
Number of pages	7
Journal	Clinical Drug Investigation
Volume	45
Issue number	6
DOIs	https://doi.org/10.1007/s40261-025-01440-z
Publication status	Published - 2025

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Keywords

psoriasis

Access to Document

10.1007/s40261-025-01440-z

Cite this

Esposito, M., Gisondi, P., Assorgi, C., Bellinato, F., Brianti, P., Burlando, M., Brunasso, G., Caccavale, S., Caldarola, G., Campione, E., Calzavara, P. P., Campanati, A., Carrera, C. G., Carugno, A., Cozzani, E., Costanzo, A., Cusano, F., Dapavo, P., Dattola, A., ... Balato, A. (2025). Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis). Clinical Drug Investigation, 45(6), 309-315. https://doi.org/10.1007/s40261-025-01440-z

@article{0639572ac75b4a70abd3691742865017,

title = "Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)",

keywords = "psoriasis, psoriasis",

author = "M. Esposito and P. Gisondi and C. Assorgi and F. Bellinato and P. Brianti and M. Burlando and G. Brunasso and S. Caccavale and Giacomo Caldarola and E. Campione and Calzavara, \{Pinton P.\} and A. Campanati and Carrera, \{C. G.\} and A. Carugno and E. Cozzani and A. Costanzo and F. Cusano and P. Dapavo and A. Dattola and \{De Simone\}, Clara and Di, \{Caprio R.\} and F. Diotallevi and Fargnoli, \{M. C.\} and F. Gaiani and A. Giunta and P. Malagoli and Marzano, \{A. V.\} and M. Megna and Mercuri, \{S. R.\} and E. Mortato and A. Narcisi and D. Orsini and L. Potestio and P. Quaglino and Richetta, \{A. G.\} and F. Romano and P. Sena and E. Vagnozzi and M. Venturini and F. Loconsole and A. Balato",

year = "2025",

doi = "10.1007/s40261-025-01440-z",

language = "English",

volume = "45",

pages = "309--315",

journal = "Clinical Drug Investigation",

issn = "1173-2563",

publisher = "Adis",

number = "6",

}

Esposito, M, Gisondi, P, Assorgi, C, Bellinato, F, Brianti, P, Burlando, M, Brunasso, G, Caccavale, S, Caldarola, G, Campione, E, Calzavara, PP, Campanati, A, Carrera, CG, Carugno, A, Cozzani, E, Costanzo, A, Cusano, F, Dapavo, P, Dattola, A, De Simone, C, Di, CR, Diotallevi, F, Fargnoli, MC, Gaiani, F, Giunta, A, Malagoli, P, Marzano, AV, Megna, M, Mercuri, SR, Mortato, E, Narcisi, A, Orsini, D, Potestio, L, Quaglino, P, Richetta, AG, Romano, F, Sena, P, Vagnozzi, E, Venturini, M, Loconsole, F & Balato, A 2025, 'Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)', Clinical Drug Investigation, vol. 45, no. 6, pp. 309-315. https://doi.org/10.1007/s40261-025-01440-z

TY - JOUR

T1 - Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)

AU - Esposito, M.

AU - Gisondi, P.

AU - Assorgi, C.

AU - Bellinato, F.

AU - Brianti, P.

AU - Burlando, M.

AU - Brunasso, G.

AU - Caccavale, S.

AU - Caldarola, Giacomo

AU - Campione, E.

AU - Calzavara, Pinton P.

AU - Campanati, A.

AU - Carrera, C. G.

AU - Carugno, A.

AU - Cozzani, E.

AU - Costanzo, A.

AU - Cusano, F.

AU - Dapavo, P.

AU - Dattola, A.

AU - De Simone, Clara

AU - Di, Caprio R.

AU - Diotallevi, F.

AU - Fargnoli, M. C.

AU - Gaiani, F.

AU - Giunta, A.

AU - Malagoli, P.

AU - Marzano, A. V.

AU - Megna, M.

AU - Mercuri, S. R.

AU - Mortato, E.

AU - Narcisi, A.

AU - Orsini, D.

AU - Potestio, L.

AU - Quaglino, P.

AU - Richetta, A. G.

AU - Romano, F.

AU - Sena, P.

AU - Vagnozzi, E.

AU - Venturini, M.

AU - Loconsole, F.

AU - Balato, A.

PY - 2025

Y1 - 2025

KW - psoriasis

UR - https://publicatt.unicatt.it/handle/10807/323748

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=105005402569&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105005402569&origin=inward

U2 - 10.1007/s40261-025-01440-z

DO - 10.1007/s40261-025-01440-z

M3 - Article

SN - 1173-2563

VL - 45

SP - 309

EP - 315

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

IS - 6

ER -

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis)

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Cite this